American Well Corporation Class A AMWL 深 沪
已收盘 02-13 16:00:00 美东时间
5.40
+1.070
+24.71%
华盛通- 最 高5.8899
- 今 开4.55
- 成交量 71.78万股
- 最 低 4.55
- 昨 收 4.33
- 总市值 8840.47万
- 52周最高 12.00
- 市盈率 静 --
- 换手率 4.38%
- 52周最低 3.71
- 委 比 -20.48%
- 总股本 1637.12万
- 历史最高 875.00
- 量 比 4.02
- 振 幅 30.94%
- 历史最低 3.71
- 每 手 1
- 风险率 1.77%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多American Well’s Earnings Call Maps Painful Reset
American Well Corporation (($AMWL)) has held its Q4 earnings call. Read on for ...
今天 08:22
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers American Well (NYSE:AMWL) stock moved upwards by 31.2% to $5.68 during...
02-14 01:05
Stifel Maintains Hold on American Well, Lowers Price Target to $5
Stifel analyst David Grossman maintains American Well (NYSE:AMWL) with a Hold and lowers the price target from $6 to $5.
02-14 00:32
American Well Sees Q1 Sales $48.000M-$53.000M vs $57.824M Est
American Well (NYSE:AMWL) sees Q1 sales of $48.000 million-$53.000 million vs $57.824 million analyst estimate.
02-13 05:34
Insights into American Well Q4 Earnings
American Well (NYSE:AMWL) just disclosed its Q4 earnings on Thursday, February ...
02-13 05:34
American Well Q4 EPS $(1.52) Beats $(1.75) Estimate, Sales $55.308M Beat $52.699M Estimate
American Well (NYSE:AMWL) reported quarterly losses of $(1.52) per share which beat the analyst consensus estimate of $(1.75) by 13.14 percent. This is a 45.13 percent increase over losses of $(2.77) per share from the
02-13 05:33
Earnings Scheduled For February 12, 2026
Companies Reporting Before The Bell • Ambev (NYSE:ABEV) is estimated to report ...
02-12 19:11
A Glimpse of American Well's Earnings Potential
American Well (NYSE:AMWL) is preparing to release its quarterly earnings on Thu...
02-12 04:01
American Well Extends Elevance Health Digital Care Partnership
American Well ( ($AMWL) ) has shared an update. On December 24–25, 2025, Americ...
01-03 06:50
美股大行评级 | 潜在涨幅101%！12家机构集体上调美光目标价；Insmed、RPM、Vital Farms等遭多家大行下调评级
今日重点评级关注：Ascendiant Capital：维持Society Pass"买入"评级，目标价从22美元升至22.5美元；HC Wainwright & Co.：维持Climb Bio"买入"评级，目标价从9美元升至11美元
2025-12-19 10:15
